The diagnostic sensitivity of TIMP-1 was higher (61%) than that of the serum levels of other biomarkers (MMP-9—55%; TIMP-2—59%, MMP-2—46%) as well as the classical tumor markers (CEA and CA 19-9), and increased in combined use with CEA. The gene discussed is TIMP1; the disease is neoplasm.